Patients with HIV Diagnosed with Cancer Have Increased Mortality Rates Tops SPT Week in Review

Article

Top news of the week from Specialty Pharmacy Times.

5. Survival Benefit Demonstrated with Abemaciclib Among Women with Metastatic Disease

Eli Lilly has announced that interim data from a phase 3 shows proof of a survival benefit with their breast cancer drug abemaciclib (Verzenio) among women with metastatic disease, read more.

4. New PrEP Approach Reduces Number of Pills Needed

Health officials in San Francisco are promoting a new strategy for administering pre-exposure prophylaxis for those at risk of contracting HIV, read more.

3. Patients with Psoriasis May Be at Elevated Risk of Cancer

A recent meta-analysis showed that patients with psoriasis may be at an increased risk of cancer, read more.

2. Predictive AI Causes Privacy Concerns

A London-based artificial intelligence company has developed a system that can analyze a patient’s health records, such as blood tests, and predict acute kidney disease up to 48 hours before onset; however, the technique has caused privacy concerns, read more.

1. Patients with HIV Diagnosed with Cancer Have Increased Mortality Rates

People living with HIV who are diagnosed with cancer have increased mortality rates compared with patients diagnosed with cancer who are not HIV positive, read more.

Related Videos
Image Credit: SciePro - stock.adobe.com
Pharmacist selling medications in the pharmacy | Image Credit: rh2010 - stock.adobe.com
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.